Cargando…
Co-Regulation of Histone-Modifying Enzymes in Cancer
Cancer is characterized by aberrant patterns of expression of multiple genes. These major shifts in gene expression are believed to be due to not only genetic but also epigenetic changes. The epigenetic changes are communicated through chemical modifications, including histone modifications. However...
Autores principales: | Islam, Abul B. M. M. K., Richter, William F., Jacobs, Laura A., Lopez-Bigas, Nuria, Benevolenskaya, Elizaveta V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160334/ https://www.ncbi.nlm.nih.gov/pubmed/21886846 http://dx.doi.org/10.1371/journal.pone.0024023 |
Ejemplares similares
-
Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells
por: Váraljai, Renáta, et al.
Publicado: (2015) -
Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets
por: Beshiri, Michael L., et al.
Publicado: (2010) -
Ubiquitin Regulation: The Histone Modifying Enzyme′s Story
por: Wang, Jianlin, et al.
Publicado: (2018) -
Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer
por: Aissa, Alexandre F., et al.
Publicado: (2021) -
Nitric oxide inhibits FTO demethylase activity to regulate N(6)-methyladenosine mRNA methylation
por: Kuschman, Hannah Petraitis, et al.
Publicado: (2023)